// App-Quantinova.ai

PO1681 : Using the Difference in Estimated Glomerular Filtration Rate by Cystatin C vs. by Serum Creatinine (eGFRDiff) to Assess Muscle Mass and Frailty in Older Adults

Researchers

Presenter

  • Potok O. Alison

Principal Investigators

  • Ix JoachimH

  • Shlipak Michael

  • Bansal Nisha

  • Katz Ronit

  • Kritchevsky StephenB

  • Rifkin DenaE

Medical Centers

  • University of California, San Francisco, San Francisco, California, United States

  • San Francisco Veterans Affairs Medical Center, San Francisco, California, United States

  • University of Washington, Seattle, WA, United States

  • Wake Forest School of Medicine, Winston-Salem, North Carolina, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • Leukodystrophy, hypomyelinating, 6

Biomarkers

  • Cystatin C

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved